• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻素与心血管系统。

Cannabinoids and Cardiovascular System.

机构信息

Circulatory Physiology Department, Bogomoletz Institute of Physiology National Academy of Sciences of Ukraine, Kiev, Ukraine.

出版信息

Adv Exp Med Biol. 2019;1162:63-87. doi: 10.1007/978-3-030-21737-2_5.

DOI:10.1007/978-3-030-21737-2_5
PMID:31332735
Abstract

Cannabinoids influence cardiovascular variables in health and disease via multiple mechanisms. The chapter covers the impact of cannabinoids on cardiovascular function in physiology and pathology and presents a critical analysis of the proposed signalling pathways governing regulation of cardiovascular function by endogenously produced and exogenous cannabinoids. We know that endocannabinoid system is overactivated under pathological conditions and plays both a protective compensatory role, such as in some forms of hypertension, atherosclerosis and other inflammatory conditions, and a pathophysiological role, such as in disease states associated with excessive hypotension. This chapter focuses on the mechanisms affecting hemodynamics and vasomotor effects of cannabinoids in health and disease states, highlighting mismatches between some studies. The chapter will first review the effects of marijuana smoking on cardiovascular system and then describe the impact of exogenous cannabinoids on cardiovascular parameters in humans and experimental animals. This will be followed by analysis of the impact of cannabinoids on reactivity of isolated vessels. The article critically reviews current knowledge on cannabinoid induction of vascular relaxation by cannabinoid receptor-dependent and -independent mechanisms and dysregulation of vascular endocannabinoid signaling in disease states.

摘要

大麻素通过多种机制影响心血管变量在健康和疾病。本章涵盖了大麻素对心血管功能在生理学和病理学中的影响,并对拟议的信号通路进行了批判性分析,这些信号通路控制内源性和外源性大麻素对心血管功能的调节。我们知道,在病理条件下,内源性大麻素系统过度激活,发挥保护代偿作用,如在某些形式的高血压、动脉粥样硬化和其他炎症状态下,以及发挥病理生理作用,如与过度低血压相关的疾病状态下。本章重点介绍影响大麻素在健康和疾病状态下对血液动力学和血管舒缩作用的机制,强调了一些研究之间的不匹配。本章首先回顾了吸烟对心血管系统的影响,然后描述了外源性大麻素对人类和实验动物心血管参数的影响。接下来,分析了大麻素对分离血管反应性的影响。本文批判性地回顾了当前关于大麻素通过大麻素受体依赖性和非依赖性机制诱导血管舒张以及在疾病状态下血管内源性大麻素信号转导失调的知识。

相似文献

1
Cannabinoids and Cardiovascular System.大麻素与心血管系统。
Adv Exp Med Biol. 2019;1162:63-87. doi: 10.1007/978-3-030-21737-2_5.
2
Blood pressure regulation by endocannabinoids and their receptors.内源性大麻素及其受体对血压的调节作用。
Neuropharmacology. 2005 Jun;48(8):1130-8. doi: 10.1016/j.neuropharm.2004.12.005. Epub 2005 Feb 19.
3
Cardiovascular pharmacology of cannabinoids.大麻素的心血管药理学
Handb Exp Pharmacol. 2005(168):599-625. doi: 10.1007/3-540-26573-2_20.
4
[Cardiovascular effects of cannabinoids].[大麻素的心血管效应]
Orv Hetil. 2002 Jun 30;143(26):1563-8.
5
Naturally Occurring Cannabinoids and their Role in Modulation of Cardiovascular Health.内源性大麻素及其在调节心血管健康中的作用。
J Diet Suppl. 2020;17(5):625-650. doi: 10.1080/19390211.2020.1790708. Epub 2020 Jul 17.
6
Physiology of the Endocannabinoid System During Development.内源性大麻素系统在发育过程中的生理学。
Adv Exp Med Biol. 2019;1162:13-37. doi: 10.1007/978-3-030-21737-2_2.
7
Cannabinoid signaling in health and disease.健康与疾病中的大麻素信号传导
Can J Physiol Pharmacol. 2017 Apr;95(4):311-327. doi: 10.1139/cjpp-2016-0346. Epub 2017 Mar 6.
8
Cardiovascular effects of endocannabinoids--the plot thickens.内源性大麻素的心血管效应——情况愈发复杂了。
Prostaglandins Other Lipid Mediat. 2000 Apr;61(1-2):71-84. doi: 10.1016/s0090-6980(00)00056-3.
9
The complexities of the cardiovascular actions of cannabinoids.大麻素心血管作用的复杂性。
Br J Pharmacol. 2004 May;142(1):20-6. doi: 10.1038/sj.bjp.0705725.
10
A Review of Cardiovascular Effects of Marijuana Use.大麻使用对心血管影响的综述
J Cardiopulm Rehabil Prev. 2025 Jan 1;45(1):2-7. doi: 10.1097/HCR.0000000000000923. Epub 2024 Dec 26.

引用本文的文献

1
Investigating the Role of Cannabinoid Type 1 Receptors in Vascular Function and Remodeling in a Hypercholesterolemic Mouse Model with Low-Density Lipoprotein-Cannabinoid Type 1 Receptor Double Knockout Animals.研究低密度脂蛋白-大麻素 1 型受体双敲除动物的高胆固醇血症小鼠模型中大麻素 1 型受体在血管功能和重塑中的作用。
Int J Mol Sci. 2024 Sep 2;25(17):9537. doi: 10.3390/ijms25179537.
2
Pharmacology of Non-Psychoactive Phytocannabinoids and Their Potential for Treatment of Cardiometabolic Disease.非精神活性植物大麻素的药理学及其治疗心血管代谢疾病的潜力。
Handb Exp Pharmacol. 2025;287:61-93. doi: 10.1007/164_2024_731.
3
Association of Cannabis Use Disorder With Hospitalizations for Pulmonary Embolism and Subsequent in-Hospital Mortality in Young Adults: A Contemporary Nationwide Analysis.
大麻使用障碍与青年肺栓塞住院及院内死亡的相关性:一项当代全国性分析。
J Am Heart Assoc. 2024 Jul 2;13(13):e032787. doi: 10.1161/JAHA.123.032787. Epub 2024 Jun 27.
4
Role of CB1 Cannabinoid Receptors in Vascular Responses and Vascular Remodeling of the Aorta in Female Mice.CB1 cannabinoid 受体在雌性小鼠主动脉血管反应和血管重塑中的作用。
Int J Mol Sci. 2023 Nov 17;24(22):16429. doi: 10.3390/ijms242216429.
5
Cannabis use disorder and adverse cardiovascular outcomes: A population-based retrospective cohort analysis of adults from Alberta, Canada.大麻使用障碍与不良心血管结局:基于加拿大艾伯塔省成年人的人群回顾性队列分析。
Addiction. 2024 Jan;119(1):137-148. doi: 10.1111/add.16337. Epub 2023 Sep 27.
6
Delta 9-tetrahydrocannabinol conserves cardiovascular functions in a rat model of endotoxemia: Involvement of endothelial molecular mechanisms and oxidative-nitrative stress.δ9-四氢大麻酚在脂多糖诱导的内毒素血症大鼠模型中对心血管功能的保护作用:涉及内皮分子机制和氧化应激。
PLoS One. 2023 Jun 16;18(6):e0287168. doi: 10.1371/journal.pone.0287168. eCollection 2023.
7
The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases.内源性大麻素系统在年龄相关性疾病中的治疗潜力
Biomedicines. 2022 Oct 6;10(10):2492. doi: 10.3390/biomedicines10102492.
8
Why Multitarget Vasodilatory (Endo)cannabinoids Are Not Effective as Antihypertensive Compounds after Chronic Administration: Comparison of Their Effects on Systemic and Pulmonary Hypertension.为何多靶点血管舒张性(内源性)大麻素在长期给药后不能作为有效的抗高血压化合物:其对系统性高血压和肺动脉高压作用的比较
Pharmaceuticals (Basel). 2022 Sep 7;15(9):1119. doi: 10.3390/ph15091119.
9
Vasoprotective Endothelial Effects of Chronic Cannabidiol Treatment and Its Influence on the Endocannabinoid System in Rats with Primary and Secondary Hypertension.慢性大麻二酚治疗对原发性和继发性高血压大鼠的血管保护内皮作用及其对内源性大麻素系统的影响
Pharmaceuticals (Basel). 2021 Oct 31;14(11):1120. doi: 10.3390/ph14111120.
10
Cannabinoids-A New Perspective in Adjuvant Therapy for Pulmonary Hypertension.大麻素——肺动脉高压辅助治疗的新视角。
Int J Mol Sci. 2021 Sep 17;22(18):10048. doi: 10.3390/ijms221810048.